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Arenaviridae comprises 23 recognized virus species with a bipartite ssRNA genome and an ambisense coding strategy. The virions
are enveloped and include nonequimolar amounts of each genomic RNA species, designated L and S, coding for four ORFs (N,
GPC, L, and Z). The arenavirus Jun´ ın (JUNV) is the etiological agent of Argentine Hemorrhagic Fever, an acute disease with
high mortality rate. It has been proposed that Z is the functional counterpart of the matrix proteins found in other negative-
stranded enveloped RNA viruses. Here we report the optimized expression of a synthetic gene of Z protein, using three expression
systems (two bacterial and a baculoviral one). One of these recombinant proteins was used to generate antibodies. A bioinformatic
analysis was made where Z was subdivided into three domains. The data presented contributes methodologies for Z recombinant
production and provides the basis for the development of new experiments to test its function.
1.Introduction
Jun´ ın virus (JUNV) is a South American arenavirus, the
etiological agent of a severe endemo-epidemic disease called
Argentine Hemorrhagic Fever (AHF).
Arenaviridae is a family composed of a growing num-
ber of enveloped viruses with a bipartite single stranded
RNA genome. Members of the Arenaviridae family were
subdivided into two groups based on the geographical
site of isolation, serological cross-reactivity and genetic
data. The prototype of the family, lymphocytic chori-
omeningitis virus (LCMV) is a member of the Old
World arenavirus group, which also includes Ippy (IPPV),
Lassa (LASV), Mobala (MOBV), and Mopeia (MOPV)
viruses. JUNV is a member of the New World arenavirus
group, that also includes Allpahuayo (ALLV), Amapari
(AMAV), Bear Canyon (BCNV), Flexal (FLXV), Guanarito
(GTOV), Latino (LATV), Machupo (MACV), Oliveros
(OLVV), Paran´ a (PARV), Pichind´ e (PICV), Pirital (PIRV),
Sabi´ a (SABV), Tacaribe (TCRV), Tamiami (TAMV), and
Whitewater Arroyo (WWAVs) viruses [1]. In addition,
there are several recently described species that have
not yet been classiﬁed by the ICTV (http://www.ictvon-
line.org/virusTaxonomy.asp?version=2008=2008).
The two RNA segments of the Jun´ ın virus genome are
designated L and S and have approximate sizes of 7.2 and
3.5kb, respectively. Each RNA segment directs the synthesis
of two proteins; their open reading frames are arranged
in opposite orientations (ambisense coding strategy) [2]
and are separated by a noncoding intergenic region that
folds into a stable stem-loop structure [3] .T h eSR N A
codes for the major structural proteins of the virion: the
precursor of the envelope glycoproteins (GPC) and the viral
nucleocapsid protein (N). Posttranslational cleavage of GPC
renders a signal peptide and the two viral glycoproteins (GP1
and GP2). The L RNA segment codes for the viral RNA-
dependent RNA polymerase (L) and the small protein (Z).
Z is a 94 residue long polypeptide, and its central portion is
predicted to fold into a RING ﬁnger domain. Moreover, Z
h a sb e e ni m p l i c a t e di ns e v e r a la s p e c t so fa r e n a v i r u sb i o l o g y
[4–6].
Based on nucleotide sequence data, a better compre-
hension of the taxonomy and evolution of the Arenaviridae
has been achieved. It has been suggested that New World2 Journal of Biomedicine and Biotechnology
arenaviruses should be classiﬁed into four diﬀerent lineages,
named A, B, C, and Rec [7]. Lineage A would contain ALLV,
FLXV, PARV, PICV and PIRV; lineage B contains AMAV,
GTOV, JUNV, MACV, SABV, and TCRV, lineage C contains
LATV and OLVV, and lineage Rec, with the WWAV, TAMV,
and BCNV. Members of this last clade are thought to have a
recombinant S RNA. Currently (ICTV website) the last three
viruses are classiﬁed with Clade A.
The role of Z in the virus life cycle is not com-
pletely elucidated, and homologues of Z are not found in
other ambisense or negative-stranded RNA viruses. Z is
a structural component of the virion [8], and by means
of in vivo and in vitro experiments, the interaction of Z
with several cellular factors has been reported, including
the promyelocytic leukemia protein and the eukaryotic
translation initiation factor 4E [9, 10]. Because of this latter
interaction, it was proposed that Z inhibits Cap-mediated
translation [11, 12]. Other researchers suggested that Z
could be a transcriptional regulator of the viral cycle [13]
or even an inhibitor of viral replication [14]. Furthermore,
P´ erez and coworkers [15] proposed, for LCMV and LASV,
that Z is the functional counterpart of the matrix proteins
found in other negative-stranded enveloped RNA viruses.
Latedomains(LDs),foundinmatrixproteinsfromnegative-
stranded RNA viruses and in Gag protein from retroviruses,
haveanessentialroleintheviralbuddingprocess[16].Three
types of motifs have been deﬁned within viral LDs: P[TS]AP,
PPxY, and YxxL [17], where “x” is any amino acid. Later,
Mart´ ın Serrano and coworkers [18] redeﬁned the last as:
YPxL/LxxLF. LDs are highly conserved and have been shown
to mediate interaction with host cell proteins, in particular
with members of the vacuolar protein-sorting pathway [19,
20]. For instance, the PTAP motif from Ebola virus VP40
matrix protein and from HIV Gag protein interacts with
Tsg101, a member of the vacuolar protein-sorting pathway.
In this work, we show the strategies employed for the
expression, puriﬁcation, and speciﬁc antibody generation
against Z protein from Candid#1 strain of Jun´ ın virus [21].
Here we report the optimized expression from a synthetic
gene of Z protein tagged with diﬀerent peptides, using three
expression systems (two bacterial and a baculoviral one), in
ordertoobtainrecombinantZproteinsuitableforfunctional
characterization studies.
2.MaterialsandMethods
2.1. Virus and Cell Culture. The passage history of JUNV
Candid#1 strain was described previously [21]. The parental
Jun´ ın virus XJ strain was isolated in Jun´ ın city (Buenos
Aires, Argentina) from a human AHF patient [22]. The
BHK21 cells were cultured in growth medium (Dulbecco’s
minimal essential medium—DMEM—supplemented with
10% fetal bovine serum and 2mM L-glutamine) to 50%
conﬂuenceandinfectedatamultiplicityofinfection(moi)of
1 plaque forming unit (pfu) per cell. After virus adsorption
for 1h at room temperature, infected cells were washed
with phosphate-buﬀered saline (PBS) and maintained at
37
◦C in MEM containing 2% fetal bovine serum. Virions
were recovered and puriﬁed from the supernatant media;
viral and total infected cell RNAs were isolated according
to procedures described previously [3]. Virus titers were
determined by plaque assay on Vero E6 (ATCC, CCL 1586,
C1008) cell monolayers as described elsewhere [3]. The cell
monolayers were harvested 72h post infection by scraping
and recovered by centrifugation.
2.2. RNA Isolation, Ampliﬁcation, and Cloning. RNA was
isolated from pelleted virions or infected cells, using the
QIAmp Viral RNA Mini Kit or RNeasy Mini Kit (Qiagen,
Valencia, CA). The Z open reading frame (ORF) from JUNV
Candid#1 strain, was ampliﬁed by RT-PCR (SuperScript
III Reverse Transcriptase for RT, and Platinum Taq DNA
Polymerase High Fidelity for PCR, Invitrogen), from Jun´ ın
virus RNA using the forward primer JZv 5 -ATGGGC-
AACTGCAACGGGGCATC-3  (ZORFtranslationinitiation
sequence is underlined), and the reverse primers JZvc 5 -
TGGTGGTGGTGCTGTTGGCTCCAC-3 ,a n dJZvc-Stop:
5 -CTATGGTGGTGGTGCTGTTGGCTCCAC-3  (sequence
complementary to the Z stop codon is underlined). The
amplicon was cloned into pZErO and the recombinant
plasmid(ZpZ)wasampliﬁedinEscherichiacolistrainTOP10
(Invitrogen). The recombinant plasmids were conﬁrmed by
nucleotide sequencing.
For cloning Z ORF into pET102/D-TOPO (Invitrogen),
a variant from JZv primer was used, named JZvClamp:
5 -CCACATGGGCAACTGCAACGGGGCATC-3  (the four
nucleotides, added to facilitate cloning, upstream of the
ATG initiation codon, are indicated in italics). The amplicon
obtained with JZvC and JZvClamp was cloned following
the manufacturer’s instructions. The recombinant clone
was named pET-Z and used for expression experiments in
bacterial cell culture (E. coli BL21). The produced protein
was fused to diﬀerent tags: Thioredoxine by the N-terminus,
and His Tag and V5 epitopes by the C-terminus. This fusion
protein was called Tio-Z-V5-His.
For the subsequent cloning procedures the plasmid ZpZ
was digested with XhoI and HindIII. This digestion rendered
a product of 366bp, comprising Z ORF and a portion of
the alpha fragment of lacZ (from pZErO MCS), hereafter
designated as z . This fragment was cloned into diﬀerent
expression vectors:
(a) pGZ (pGEX-B, Novagen). The z  fragment was
ligated into pQE-30 (Qiagen, Valencia, CA) previ-
ously digested with HindIII and SalI. The obtained
plasmid, pQZ was digested with SmaI and HindIII
and the 374pb fragment was ligated into pGEX-
B, previously digested with the same enzymes.
The recombinant plasmid (pGZ) was ampliﬁed
in E. coli DH5α (Invitrogen) and conﬁrmed by
nucleotide sequencing. pGZ was used for expression
experiments in bacterial cell culture. The recombi-
nant protein, called GST-Z, contains Glutathione-S-
transferase (GST) fused to the N-terminus of Z.
(b) pBAC-Z (pFastBac-HTa, Invitrogen). The z  frag-
ment was ligated into the vector pFastBac-HTa,
previouslydigestedwithHindIIIandSalI.ZORFwasJournal of Biomedicine and Biotechnology 3
fused to a His-Tag to the amino end of Z. This His-
Tagged version of Z was named Z-His. The recom-
binant plasmid (pBAC-Z) was ampliﬁed in E. coli
TOP10 and the insert was conﬁrmed by nucleotide
sequencing. The Bac-to-Bac system (Invitrogen) was
used to generate recombinant baculoviral genomes
(AcMNPV) harboring Z-His gene (Bacmid Ac-Z).
Brieﬂy, Z ORF in pBAC-Z was transposed to an
AcMNPV genome using E. coli strain DH10 BAC,
which carries the target baculoviral genome and the
machinery required for transposition. The recombi-
nant AcMNPV genomes (Bacmid Ac-Z) were puri-
ﬁed by minipreparation from bacterial culture and
then used to generate recombinant baculoviruses
(v Ac-Z) by transfecting diﬀerent insect cell lines
(Cellfectin, Invitrogen).
2.3. Protein Expression in Insect Cell Lines. The recombinant
baculovirus (v Ac-Z) was ampliﬁed by infection of insect
cells. Viruses were recovered from the supernatant media of
infected cell monolayers and puriﬁed by ultracentrifugation.
Virus titers were determined by plaque assay. Optimization
procedures of the expression levels consisted in testing
diﬀerent multiplicities of infection and insect cell lines. Two
cell lines were used, SF9 from Spodoptera frugiperda [23]a n d
High Five (BTI-TN-5B1-4) from Trichoplusia ni [24]. These
c e l l sw e r ec u l t u r e do n2 5c m 2 polystyrene ﬂasks with Grace
medium (Invitrogen), supplemented with 10% fetal bovine
serum and 0.1% gentamicin, to 70% conﬂuence and infected
withtherecombinantbaculovirus(> 107 pfu/ml)atdiﬀerent
multiplicities of infection (moi). After virus adsorption for
1h at room temperature, infected cells were washed with
phosphate-buﬀered saline (PBS) and maintained at 25
◦C
in Grace containing 10% fetal bovine serum. The protein
expression was analyzed by SDS-PAGE and Western blotting
using Z protein-speciﬁc antibodies and His-Tag antibodies.
2.4. Protein Expression in Bacterial Cells. Av a r i e t yo fe x p r e s -
sion strains were tested: Rosetta pLys and Origami B (DE3)
from Novagen; BL21 (DE3), BL21 (pLysS), BL21-CodonPlus
(DE3) RIPL and XL1Blue from Stratagene; BL21 SI from
Invitrogen; OverExpress C41 (DE3) and C43 (DE3) from
Lucigen. Cells were grown on Luria broth (LB) growth
medium [25] and supplemented with the proper antibiotic
when required (34μg/ml kanamycin, 100μg/ml ampicillin,
50μg/ml chloramphenicol, 12.5μg/ml tetracycline).
(a) Tio-Z-V5-His (pT-Z). For Tio-Z-V5-His fusion pro-
tein, the best expression level was observed with
BL21 (DE3) strain. Transformed cells were cultured
in 500ml of LB medium containing 100μg/ml
ampicillin, at 37
◦C. When the culture absorbance at
600nm reached a value of 1.5, cells were induced
with 600μM isopropyl-β-D-thiogalactopyranoside
(IPTG) for 4h at 37
◦C. Bacteria were then har-
vested by centrifugation at 4000×g for 15min, and
r e s u s p e n d e di n2 5 m lo f5 0 m MN a H 2PO4 pH 8.2;
300mM NaCl; 20mM Imidazole; 1% Triton X-100
and complete Protease Inhibitor Cocktail Tablets
1X (Roche). Cells were disrupted by French Press
and, after centrifugation at 20,000×g for 30min,
the soluble fraction was collected and analyzed by
SDS-PAGE (4X Loading sample buﬀer containing
200 mM Tris-HCl, 8% SDS, 40% glycerol, and 0.4%
Bromophenol Blue and 400 mM DTT, pH 6.8). SDS-
PAGEanalyseswereperformedaccordingtoLaemmli
[26], using 12–15% polyacrylamide gels stained with
R250 Coomassie blue. The running buﬀer was Tris-
Glycine [27].
(b) GST-Z (pGEX-Z). Very similar expression levels
were obtained from the diﬀerent host cells studied
for the GST-Z fusion protein, as detected by Tris-
Glycine 15% SDS-PAGE. The selected strain and
culture conditions were the same as employed by
Volpon and coworkers [28], with buﬀers containing
Zn+2. Bacteria were harvested by centrifugation at
4,000×g for 15min, and the pellet was resuspended
in 25ml of PBS, 200mM NaCl, pH 8; 0.1% Triton X-
100, 100μM DTT, and complete Protease Inhibitor
Cocktail Tablets 1X (Roche). Cells were disrupted by
French Press and, after centrifugation at 20,000×g
for 30min, the soluble fraction was collected and
analyzed by SDS-PAGE. Analyses were performed
according to Laemmli [26], using 12–15% polyacry-
lamide gels stained with R250 Coomassie blue. The
running buﬀer was Tris-Glycine.
The protein quantiﬁcation was made using Bradford
method and by densitometry.
2.5. Puriﬁcation of Z from Bacteria
Tio-Z-V5-His. The soluble fraction (25ml) obtained after
the induction of pET-Z was clariﬁed by centrifugation at
12,000×g for 30min and loaded on a His-Trap 5ml column
(Amersham), using a running buﬀer 50mM NaH2PO4 pH
8.2, 300mM NaCl. After column wash, a step gradient of
500mM Imidazole was applied at 1ml/min ﬂow for 20min
using an AKTA FPLC (Amersham). Each fraction collected
was analyzed by SDS-PAGE and those containing Tio-Z-
V5-His were pooled, and concentrated down to 1ml on a
spin concentrator (Vivaspin 15, 10,000 MWCO, Sartorius).
T h i sw a st h e nr u no nag e lﬁ l t r a t i o nc o l u m nS u p e r d e x
200 10/300GL (Amersham) using running buﬀer 50mM
NaH2PO4 pH 8.2, 300mM NaCl at 0.5ml/min ﬂow. Again,
every fraction was analyzed by SDS-PAGE and those con-
taining Tio-Z-V5-His were pooled and dialyzed overnight
against Tris-HCl 20mM pH 8.0 at 4◦C.
Cleavage and Puriﬁcation of Tio-Z-V5-His. Puriﬁed Tio-Z-
V5-His was dialyzed against enterokinase cleavage buﬀer
(50mM Tris-HCl pH 8; 1mM CaCl2; 0.1% Tween-20)
and then concentrated with a spin concentrator (Vivaspin
6 10,000 MWCO, Sartorius) down to 1ml at a ﬁnal
concentration of 0.3mg/ml. A fraction of 500μl of this
sample was subjected to proteolysis with enterokinase on a
ﬁnalvolumeof600μlovernightat4◦C.Afterthis,thesample
was loaded on a His-Trap 5ml column (Amersham). The4 Journal of Biomedicine and Biotechnology
running buﬀer was 50mM NaH2PO4 pH 8.2; 300mM NaCl.
Finally, a 500mM Imidazole step gradient was applied for
20min. Every fraction was analyzed by SDS-PAGE.
GST-Z. The soluble fraction (25ml), obtained after the
induction of pGZ and cell disruption by Cell Press, was
clariﬁed by centrifugation at 12,000×g for 30min, loaded
into 1ml of Glutathione Sepharose 4B (GE Healthcare),
and incubated at 4◦C overnight. After ﬁve washes with
50ml of PBS, the sample was eluted with 2ml of 25mM
reducedglutathione(Sigma)in50mMTris-HClpH 9.5.The
eluted fraction was dialyzed against phosphate buﬀer 20mM
Na2HPO4 pH 7.2a t4 ◦C overnight, concentrated down to
1ml (Vivaspin 2, 10,000 MWCO, Sartorious), and loaded
into a Superdex 200 column (Amersham) using the same
buﬀer conditions at 0.5ml/min ﬂow.
Cleavage and Puriﬁcation of GST-Z. GST-Z was dialyzed
against Factor Xa cleavage buﬀer (50mM Tris-HCl pH 7.5;
150mM NaCl; 1mM CaCl2) and 600μlo ft h i ss a m p l ew e r e
subjected to proteolysis with Factor Xa protease at room
temperature overnight. The reaction product was incubated
with glutathione sepharose for 1h at room temperature to
retain the cleaved GST fusion peptide, while Z protein was
recovered in the supernatant. Finally the bound GST protein
w a se l u t e dw i t h2 5m Mr e d u c e dg l u t a t h i o n ei n5 0m MT r i s -
HCl pH 9.5. The reaction products were analyzed by SDS-
PAGE and Western blotting with a polyclonal antiserum
speciﬁc for the Z protein.
2.6. Gel Filtration. C o l u m n sp a c k e dw i t h2 4 m lb e a dv o l -
umes of Superdex 200GL and Superdex 75GL were used to
obtain the target protein in its monomeric form. Columns
were loaded with 1ml of sample and run at 0.5ml/min
ﬂow using an AKTA FPLC (Amersham). For Tio-Z-V5-
His recombinant protein, the running buﬀer was 50mM
NaH2PO4, 300mM NaCl pH 8. For the GST-Z recombinant
protein it was 20mM Na2HPO4 pH 7.2.
Before each protein separation, a molecular weight
marker (Bio-Rad) was run for calibration purposes using the
corresponding running buﬀer.
2.7. Limited Proteolysis. A serial dilution 1/10 to 1/10,000
from a stock of 0.1mg/ml of chymotrypsin (Roche) and
trypsin (Roche) were incubated with a 0.5μg/μlo fG S T -
Z recombinant protein, for 2h at room temperature. The
reaction was stopped by adding SDS-PAGE sample buﬀer or
by incubating the reaction at −20
◦C.
2.8. Sequencing of the N-Terminus. The samples subjected to
limited proteolysis with chymotrypsin were loaded on a 15%
SDS-PAGE and blotted to a PVC membrane (Amersham).
The N-terminal sequence of relevant peptides was then
obtained using an Applied Biosystems Sequencer ABI494.
2.9. Production of Z Polyclonal Antibody. Polyclonal anti-
bodies were produced in rabbits according to standard
procedures.Brieﬂy,thepuriﬁedTio-Z-V5-Hisfusionprotein
was used to inoculate two female New Zealand white rabbits
with an average weight of 2.5kg. Before each inoculation,
the animals were bled from the marginal ear vein for
evaluation of antibody titers. For the ﬁrst injection, 50μg
of puriﬁed recombinant protein/kg of body weight were
emulsiﬁed in an equal volume of complete Freund’s adjuvant
(Sigma Chemicals Co) and administered subcutaneously.
After 25 days, the animals were bled as described above and
inoculated with 50μg of puriﬁed recombinant protein/kg of
body weight emulsiﬁed in an equal volume of incomplete
Freund’s adjuvant (Sigma Chemicals Co). This procedure
was repeated twice with a time interval of 15 days and a
last bleeding was carried out by cardiac puncture [29]. The
antibody titer was estimated by inhouse EIA as described in
Arg¨ uelles et al. [30]. Tio-Z-V5-His fusion protein was used
as antigen in diﬀerent assays, with the exception of the cutoﬀ
determination, where GST-Z was used as antigen against the
heterologous sera. Puriﬁcation of G type immunoglobulin
(IgG) fractions from antiserum was carried out by aﬃnity
chromatography on Protein G-Sepharose fast ﬂow (Pharma-
cia) according to the manufacturer’s recommendations. IgG
yield, determined by absorbance at 280nm, was 3.2mg/ml
serum.
For inhouse EIA, microtiter plates (Nunc, Roskilde,
Denmark) were coated overnight at 4◦C with Tio-Z-V5-
His fusion protein diluted to 10μg/ml in 0.1M bicarbonate
buﬀer (pH 9.6) as antigen. After this, and after each of the
following steps, the plates were washed three times with
washing solution, that is, phosphate-buﬀered saline (PBS),
0.5M NaCl, and 0.2% (v/v) Triton X-10.
Fifty microliters of each serum sample diluted 1/300 in
sample buﬀer (i.e., 1% wt/vol bovine serum albumin in
washing solution) were added to the antigen-coated wells,
and the plates were incubated at 37
◦C for 1h. Peroxidase-
conjugated antirabbit IgG (Santa Cruz Biotechnology)
diluted 1/16,000 in sample buﬀer was added at 50μl/well and
incubatedfurtherfor1hat37
◦C.Boundantibodiesandcon-
jugates were then developed with orthophenylenediamine
(Sigma Chemical Co), 30% H2O2,and citrate buﬀer pH 5.0
at a ratio of 1mg/μl/ml according to standard procedures.
The optical density (OD) was measured at a wave-
length of 490nm (OD490) (Max Line TM enzyme-linked
immunosorbent assay reader; Molecular Devices, Sunny-
vale, CA). Each serum was simultaneously tested with
corresponding control antigens, that is, preimmune serum.
The results were expressed as the value of the OD of
the control antigen subtracted from the OD of the fusion
protein antigen for each serum sample. The enzyme-linked
immunosorbent assay cutoﬀ value was estimated as the
mean OD obtained with 20 certiﬁed negative specimens
plus 3 standard deviations. These negative specimens were
heterologous sera, diluted 1/300, and the antigen used was
the GST-Z fusion protein. The peroxidase-conjugated anti-
rabbit IgG was diluted 1/16,000 [30].
2.10. Immunoblotting. The extracts of bacterial cells and
insect cell lines infected with recombinant baculovirus
were separated by SDS-PAGE (12–15% polyacrylamide gel)Journal of Biomedicine and Biotechnology 5
and blotted onto nitrocellulose membranes (Hybond P+,
Amersham Pharmacia) in Tris-glycine buﬀer containing
20% (v/v) methanol. To avoid nonspeciﬁc binding of the
antibodies, the membranes were blocked by incubation with
5% wt/vol skimmed powder milk in PBS for a minimum
of 2h at 37
◦C. For the primary antibody incubation the
blocked membrane was probed with a 1/1,000 dilution of
the polyclonal antiserum speciﬁc for the Z protein on PBS
2% casein 0.1% Tween-20 at 37
◦Cf o r1 h ,f o l l o w e db y
an incubation with horseradish-peroxidase conjugated goat
anti-rabbitIgG(SantaCruzBiotechnology),diluted1/10,000
on PBS 0.1% Tween-20 at 37
◦C for 1h. After each step the
membrane was washed three times with PBS 0.1% Tween-
20, 5minutes each time.
2.11. Proteinase K Protection Assay. Insect cell suspensions
were clariﬁed by centrifugation. Supernatants were then
ultracentrifuged in order to pellet down small particles, and
these fractions were treated with Proteinase K (0.1mg/ml,
37
◦C, 30min), or a combination of Proteinase K plus 1%
TritonX-100inthesameconditions. Proteolysiswasstopped
byadding100mMPMSFandboilingthesamplesfor10min.
Samples were then analyzed by SDS-PAGE followed by
immunoblotting.
2.12. Sequences and Bioinformatic Tools
Sequences. Amino acid sequences of the following
arenavirus were obtained from the Genbank database
(accession numbers are indicated between brackets):
AMAV-BeAn70563 (ABY59841.1), CPXV-BeAn119303
(ABY59842.1), GTOV-CVH-961104 (AAT77691.1), GTOV-
VHF-3990 (AAT77689.1), JUNV-MC2 (ABY59838.1),
JUNV-Candid#1 (AAU34182.1), MACV-MARU-222688
(AAY27821.1), MACV-9530537 (AAY27823.1), TACV
(NP 694847.1), LATV-MARU-10924 (AAY27824.1), OLVV-
3229 (ABY59840.1), PIRV-VAV488 (ABY59836.1), PIRV-
1743 (AAT77682.1), ALLV-CLHP2472 (ABY59833.1), PICV-
AN3739 (YP 138535.1), BCNV-A0060209 (ABY59834.1),
BCNV-AVA0070039 (AAX99343.1), WWAV-AV9310135
(AAX99351.1), TAMV-W10777 (AAX99348.1), LCMV-
Clone#13 (ABC96003.1), LCMV-MX (CAA10342.1),
LASV-CSF (AAO59514.1), LASV-AV (AAO59508.1),
IPPY-DakAnB188 (YP 516232.1), MOBV-Acar3080
(YP 516228.1), MOPV-AN20410 (YP 170707.1), MOPV-
Mozambique (ABC71136.1), Lujo (YP 002929492), and
Morogoro (ACJ24975.1).
Alignments. Sequence alignments were done using the
CLUSTAL X program [31, 32].
Sequence Logos. Determination of Sequence Logo was made
with the server available at http://weblogo.berkeley.edu site
[33]. Synthetically, the Sequence Logo is a graphic repre-
sentation of a multiple alignment of sequences [34]. Each
logoisconstructedfromcharactersstackingineachsequence
alignment position. The stacking height indicates the local
information content in this position, while the height of each
symbol inside the stacking is the fraction of information
content representing the frequency of each residue in that
position. Because of the characteristics of the software, and
to avoid bias towards particular species that are found over-
represented in the sequence data bank, at most two strains
for each viral species were selected. Moreover, to get a more
accurate representation, gap positions within the sequences
in the alignment were considered as another character. The
usual behavior of the software does not take into account
the gaps, calculating the values relative to the number of
sequences with an amino acid in that position. All the motif
descriptions were annotated according to the syntax rules of
Prosite [35], and represent more than 60% of all Z protein
sequences.
Biochemical Properties of Diﬀerent Recombinant Proteins.
The diﬀerent biochemical parameters were calculated from
the amino acid sequence data using the ProtParam tool
found at the ExPASy Proteomics Server (www.expasy.ch,
Proteomics Tools, Primary Structure Analysis; [36]).
3. Results
3.1. Pattern Search Using Sequences Logos. In Figure 1,
three Z protein alignments (Old World, New World, and
All Arenaviruses) are shown separately. In the top of the
ﬁgure a diagram of the Z protein is shown, identifying
three characteristic regions. We observe a myristoylation
recognition motif in the amino end region, a RING ﬁnger
domain,characterizedbythesevencysteines(atpositions43,
46, 56, 62, 65, 76, and 79 in the alignment) and one histidine
at the 59 position in the central core region, and diﬀerent
late domains (found in other viral matrix proteins) at the
carboxyl end region.
In the amino end region an island conﬁguration can
be observed for each alignment. The most conserved island
contains 7 amino acids comprising the ﬁrst two amino acids
(MG) that include the glycine modiﬁed by the myristic acid
aggregate (Gly2, completely conserved) (gray shadowed in
Figure 1). The other amino acids in this region are basic
residues (K or R), or amino acid residues with amide (Q or
N ) ,s u l f h y d r y l( C ) ,o rh y d r o x y l( So rY )g r o u p s ,p r o b a b l y
constituting additional factors for membrane attachment
[37]. The rest of the fragment has poor conservation degree,
with the exception of another island for the Old World
arenavirus group (Rx4PD, where x is any amino acid,
underlined in Figure 1).
In the Z protein core region, a homogenous distribution
of conserved sites is observed. Particularly, the 7 cysteines
and the histidine residues required for Zn2+ binding and
foldingofthepredictedRINGﬁngerdomain(grayshadowed
in Figure 1). These residues are totally conserved in the
viral family, indicating strong selection pressure for keeping
the predicted RING ﬁnger domain. Other positions within
this region also show high conservation degree between
both groups (New and Old World arenavirus). For example
residues K44,W 47,a n dL 53 are completely conserved among
all arenaviruses, suggesting they might play a critical role6 Journal of Biomedicine and Biotechnology
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Figure 1: Sequence Logos of Arenavirus Z proteins. The upper diagram shows Z protein and the three regions in which it was divided.
The other three are sequence logos, in which the X-axis indicates the relative position of amino acids in the multiple alignments. The
length of 111 residues is due to the inclusion of gaps in the multiple alignment. The diﬀerent amino acid domains described in the text are
shadowed and the newly proposed domains are underlined. (a) Sequence Logo from all selected arenavirus Z proteins. (b) Sequence Logo
from selected New World arenavirus Z proteins (ANM; AMAV-BeAn70563, CPXV-BeAn119303, GTOV-CVH-961104, GTOV-VHF-3990,
JUNV-MC2, JUNV-Candid#1, MACV-MARU-222688, MACV-9530537, TACV, LATV-MARU-10924, OLVV-3229, PIRV-VAV488, PIRV-
1743, ALLV-CLHP2472, PICV-AN3739, BCNV-A0060209, BCNV-AV-A0070039, WWAV-AV9310135, TAMV-W10777). (c). Sequence Logo
from selected Old World arenavirus Z proteins (AVM; LCMV-Clone#13, LCMV-MX, LASV-CSF, LASV-AV, IPPY-DakAnB188, MOBV-
Acar3080, MOPV-AN20410, MOPV-Mozambique, Lujo, and Morogoro).
in protein folding, or maybe protein-protein interactions
required for function, such as eIF4E interaction [12].
Furthermore, the amino end of this domain,
shows a sequence motif characteristic for each group
(L[YH]GR[YF]N, for the New World arenavirus, and
GP[ELQ][FNS], for the Old World arenavirus). Until the
moment, the role of this region is unknown, but it is
interesting to highlight that the degree of conservation is
unique within the Z protein, although diﬀering among
groups. It is therefore possible to hypothesize that this
region could be associated with the arenavirus host range.
In addition, at the carboxyl end of the RING ﬁnger domain,
another conserved site within groups is detected, described
as Kx(0,1)PLPTx[IL] (where x can be any amino acid). This
putative site is underlined in Figure 1, where it can be seen
that the conservation is stronger in the Old World arenavirus
group. Furthemore, by modifying the ﬁrst conserved leucine
in this site (L83), it was demonstrated that this residue
is involved in both the rescue of nucleocapsids and the
incorporation of glycoproteins into infectious virus-like
particles [38].
Finally, a cluster of conserved sites, in an island con-
ﬁguration, can also be found at the carboxyl end region.
This island includes the characteristic motifs found in viral
matrix proteins of retroviruses (late domains): P[TS]AP and
PPPY (gray shadowed in Figure 1). These two motifs are
present in the Old World arenavirus group, while in the
New World arenavirus group only the ﬁrst one is found.
Another late domain found but situated in the core region
was YLCL (YxxL [18, 19, 39, 40]) (underlined in Figure 1).
The YLCL motif is also present in the Tacaribe virus Z
protein and was observed not to be involved with budding
of virus like-particles [41]. Interestingly, Tacaribe Z protein
does not posses the P[TS]AP motif present in the majority
of arenaviruses including Junin Z. Another late domain
frequently identiﬁed in matrix proteins of negative-stranded
RNA viruses is ΦPxV (where Φ indicates a hydrophobic
residue and x any aminoacid, [42]), however the same was
not found in the sequence of arenaviruses Z protein.
3.2. Biochemical Properties of the Diﬀerent Recombinant Pro-
teins. For the diﬀerent fusion proteins, several parametersJournal of Biomedicine and Biotechnology 7
Table 1: Biochemical properties of the diﬀerent expressed proteins.
Protein Number of
amino acids
MW (Da) pI Extinction
coeﬃcients1
Z  106 11560.1 8.44 15970/15470
Tio-Z-V5-His 251 27339.1 6.29 30075/29450
Tio 120 12814.5 4.71 14105/13980
Z-V5-His 131 14542.5 8.43 15970/15470
GST-Z 331 37855.6 6.79 59080/58330
GST 225 26293.2 6.00 43110/42860
His-Z 136 15432.4 7.09 21930/21430
1Calculated extinction coeﬃcients in M−1 cm−1 units, measured to 280 nm
in water. Left numbers correspond to the calculation assuming that all Cys
residues appear as half cystines, while the right numbers correspond to the
calculation assuming that no Cys residues appear as half cystines.
were calculated and are shown in Table 1. These values
were taken into account for expression and puriﬁcation
optimization. The Z
  protein indicates the product of
translation from the 366bp fragment (z ).
3.3. Polyclonal Serum Titer and Cutoﬀ Determination. Near
90daysafterﬁrstinoculationwiththeTio-Z-V5-His protein,
the inoculated rabbits were heart bled, obtaining 30ml
of blood. After serum separation, the same was used to
determine the cutoﬀ value, yielding a number of 0.165.
Afterwards, the polyclonal serum titer was determined,
deﬁned as the bigger serum dilution that renders a positive
reaction (more than the cutoﬀ value). For this determi-
nation, the assay conditions were the same as those in
the assay cutoﬀ determination, obtaining an antiserum
titer of 128,000. Then, the IgGs were puriﬁed by aﬃnity
chromatography to later obtain more speciﬁc Z detection.
The diﬀerent fractions were analyzed by SDS-PAGE (data
not shown) and quantiﬁed by Bradford method using a
goat IgG as concentration reference in a calibration curve.
The IgG ﬁnal concentration was 3.19mg/ml. These puriﬁed
immunoglobulins were later used in Western blotting assays.
3.4. Tio-Z-V5-His. The expression proﬁle of the recom-
binant Tio-Z-V5-His protein is shown in Figure 2.I n
Figure 2(a) a diagram of the expressed recombinant ORF
is shown. In Figure 2(b) the lanes corresponding to T0
indicate the moment when the IPTG was added to the
culture, while the TF lanes indicate the ﬁnal culture time.
After induction, a protein of expected size was expressed
(Figure 2(b)). Following cell disruption, pellet and soluble
fractions were separated. SDS-PAGE analysis conﬁrmed it
was possible to obtain a considerable amount of Tio-Z-V5-
His in the soluble fraction (Figure 2(c)). The soluble fraction
of Tio-Z-V5-His was loaded into a His-Trap column and
monitored at UV280 and UV254. The peak fractions were
collectedandanalyzedby12%SDS-PAGE,containingamain
band corresponding to the molecular weight of Tio-Z-V5-
His (ca. 27 kDa) (Figure 2(d)). Final yield of pure Tio-Z-V5-
His protein was between 10 and 12mg per liter of culture.
In order to further purify Tio-Z-V5-His, selected fractions
were pooled, concentrated and loaded into a Superdex 200
gel ﬁltration column (Figure 2(e)). The obtained Tio-Z-V5-
His was dialyzed, concentrated and subjected to proteolysis
with enterokinase. The cleaved products, thioredoxine (12.8
kDa) and Z-V5-His (14.5 kDa) were visible after 2h at
37
◦C incubation (Figure 2(f)). The products of this reaction
were loaded into a His-Trap column, as previously described
and two major peaks were observed after elution. The ﬁrst
peak corresponded to thioredoxine, which eluted at 100mM
imidazole concentration, and the second peak corresponded
to Z-V5-His protein, which eluted at 250mM imidazole
concentration (data not shown). The fractions of the second
peak were pooled, concentrated (Vivaspin 2 5,000 MWCO,
Sartorius) and analyzed by SDS-PAGE and Western blotting
with anti-Z IgG (Figure 2(g) and 2(h)). In both cases a band
of ca. 14 kDa corresponding to Z-V5-His was detected. The
quantiﬁcation data is showed in Table 2.
3.5. GST-Z. The expression proﬁle of the recombinant GST-
Z protein is shown in Figure 3. A diagram of the expressed
recombinant ORF can be seen in Figure 3(a). In Figure 3(b),
the overexpression of a protein with a size of about 37
kDa is shown, where the lane T0 indicates the moment
when the IPTG was added to the culture, while the TF
lane indicates the ﬁnal culture time. The soluble fraction,
after cell lysis, was mixed with Glutathione Sepharose resin
for batch puriﬁcation of the GST-Z protein. A protein
of about 37 kDa was present in the ﬁrst wash fraction;
nevertheless, it was possible to obtain signiﬁcant quantities
of a ca. 37 kDa protein retained in the Glutathione Sepharose
(Figure 3(c), lanes E1 and E2). Also, there were two extra
bands of approximately 29 kDa and 25 kDa. These two
peptides, retained together with the bigger protein, were
probably degradation products of the ca. 37 kDa GST-Z
protein.FinalyieldofpureGST-Zproteinwasbetween5and
8mg per liter of culture. The eluted fractions were pooled,
concentrated and loaded into a Superdex 200 gel ﬁltration
column. The molecular weight of the peaks was estimated
from the chromatogram proﬁle (Figure 3(d)). SDS-PAGE
analysis of the collected fractions, showed that the ca. 37
kDa band and the other two, of approximately 29 kDa
and 25 kDa, were present in diﬀerent proportions. Most of
the 37 kDa polypeptide was present at the high molecular
weight peak (ca. 700 kDa), indicating that most of the
overexpressed GST-Z protein was aggregated (Figure 3(d)),
lanes 6 to 10). In the collected fractions of the second
peak, the 37 kDa band was also detected, indicating that
a portion of the overexpressed protein was soluble and
monomeric (Figure 3(d), lanes 11 to 16). To obtain the Z
protein without the GST fusion peptide, the puriﬁed GST-
Z obtained after the glutathione sepharose puriﬁcation was
dialyzed against cleavage buﬀer and subjected to proteolysis
with Factor Xa. The reaction was analyzed by SDS-PAGE
(Figure 3(e)). The expected cleavage products, GST fusion
peptide and Z protein were observed. To conﬁrm the identity
of the last product the sample was analyzed by Western
blot with polyclonal antiserum speciﬁc for the Z protein (α-
Tio-Z-V5-His) and antibodies speciﬁc for fusion protein (α-
GST). Finally, as shown in Figure 3(f), it was possible to8 Journal of Biomedicine and Biotechnology
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Figure 2: Expression, puriﬁcation and cleavage of Tio-Z-V5-His. (a) Diagram for the recombinant Tio-Z-V5-His protein expressed in E.
coli. The dark gray region represents the thioredoxine (Tio) fusion protein; the striped block indicates the speciﬁc protease Enterokinase
(Gly-Gly-Gly-Gly-Lys↓) target sequence; the light gray region corresponds to Z protein; the black line shows the V5 epitope localization;
and the white arrow indicates the His-tag. The molecular weight of the complete recombinant protein is 27.3 kDa, the cleavage products
being 12.8 kDa (thioredoxine) and 14.5 kDa (Z-V5-His). (b) 12% SDS-PAGE of samples of the whole cell culture at initial time (T0)a n d
after 4h at 37
◦C( TF). The arrow indicates Tio-Z-V5-His recombinant protein. (c) 15% SDS-PAGE of the centrifuged cell lysate of E. coli
expressing Tio-Z-V5-His. S: supernatant from the whole cell lysate expressing Tio-Z-V5-His (soluble fraction). P: pellet from the whole cell
lysate (insoluble fraction). The arrow indicates Tio-Z-V5-His. (d) The chromatography proﬁle (upper part) corresponds to the elution of
the bound protein with an imidazole gradient (black line). Fractions 10 to 18 (indicated with a bracket) were loaded on 12% SDS-PAGE.
The arrow indicates Tio-Z-V5-His. In the lower part, is shown the 12% SDS-PAGE from Immobilized Ni2+ aﬃnity chromatography (IMAC)
His-trap (Amersham) fractions of the soluble fraction of Tio-Z-V5-His (S, from (c) part). (e) 12% SDS-PAGE of the gel ﬁltration (Superdex
200) fractions 13 to 21 (pooled), of the Tio-Z-V5-His puriﬁcation. This sample was the substrate of the cleavage with the enterokinase. (f)
15% SDS-PAGE of the cleavage of Tio-Z-V5-His with the protease enterokinase. The ﬁrst lane is the puriﬁed Tio-Z-V5-His. The following
lanes correspond to an incubation of 2:30h at 37
◦C with diﬀerent dilutions of the enterokinase (indicated with a bracket). The last lane
is Tio-Z-V5-His protein without treatment. The arrows indicate the two peptides produced by the cleavage, shown in diagram A. (g) 15%
SDS-PAGE of the puriﬁcation of Z-V5-His with IMAC. (h) Western blot of the cleavage products of Tio-Z-V5-His with Enterokinase. The
arrow indicates Z-V5-His.Journal of Biomedicine and Biotechnology 9
detect a ca. 11.5 kDa protein corresponding to Z. However,
it was evident that the cleavage reaction was incomplete,
because the full-length ca. 37 kDa polypeptide was also
detected. The ca. 29 kDa peptide was also recognized by the
Z polyclonal antiserum, strengthening the hypothesis that
it was a degradation product of GST-Z. To conﬁrm this
hypothesis, the puriﬁed GST-Z (obtained after gel ﬁltration
in the 40 kDa peak) was subjected to a limited proteolysis
with diﬀerent dilutions of Chymotrypsin. The peptides
thus obtained were subjected to N-Terminal sequencing
(Figure 3(g)). The bands indicated with I match with the
ﬁrst six amino acids of the GST protein sequence, and the
bands pointed out with II and III matched the C-terminal
of GST and the middle region of Z protein, respectively. The
quantiﬁcation data is showed in Table 2.
3.6. His-Z. Expression results obtained for the recombinant
His-Z protein are shown in Figure 4. A diagram of the tagged
protein obtained using the Bac-to-Bac expression system is
shown in Figure 4(a). The v Ac-Z construct (recombinant
bacmid) was transfected into High Five or Sf9 insect cells,
and the resulting viral stock was ampliﬁed by infection in
the same type of cells. The infection assays, optimized to
obtain high virus titers, rendered a stock with a titer of
1.2 × 109 pfu/ml. In addition to infecting diﬀerent cell lines,
diﬀerent multiplicities of infection (moi) were tested, as
shown in Figure 4(b). The assayed moi’s did not render
signiﬁcant diﬀerences in the protein expression levels. Sf9
insect cells were infected and, after 36h, the monolayer
fraction was collected and analyzed by 16% SDS-PAGE. In
this case, it was not possible to observe an overexpressed
product.
Two immunological approaches to certify His-Z expres-
sion were used. Z-His protein was detected in the cellular
fraction (lane 1 and 2, Figure 4(c)) when the puriﬁed α-Tio-
Z-V5-HisIgGwasusedinaWesternblot.Inthisexperiment,
two Z corresponding bands appeared, same as observed
previously by J´ acamo and coworkers when Tacaribe virus
recombinant Z protein was expressed [5]. Nevertheless, by
using anti-His polyclonal serum for Western blotting it was
not possible to visualize His-Z expression (Figure 4(d)). This
suggests that possibly in insect cell lines His-Z could be
subjected to a post-translational process that modiﬁes the
a m i n oe n do fH i s - Z .
In order to ascertain the location of this protein in the
supernatant fraction, the same was analyzed by Western Blot
and a Proteinase K protection assay (Figure 5).
4. Conclusions
The general aim of any heterologous expression system is to
obtain a puriﬁed protein in its native conformation. Z is a
small (approx. 11 kDa) viral protein normally expressed in
the late phases of the arenavirus infection in mammalian
cells. The recombinant overexpression of native Z protein
requiresanadequateeukaryotic expression system.However,
there are some applications for which it is not necessary to
obtain the protein in the native conformation, for example
for antibodies production. Also, it has been reported that
post-translational modiﬁcations are few in many proteins;
therefore in these cases the bacterial expression systems are
really advantageous because they have higher expression lev-
els and lower costs when compared to eukaryotic expression
systems [43]. Thus, the system will be selected depending on
the application of the recombinant product.
Using the sequence logo (Figure 1) the conservation of
amino acids for the arenaviral Z proteins was described. Z
proteins could be divided into three characteristic regions
named Amino, Core and Carboxyl regions. Each region
comprises previously described Z protein domains. The
Myristoylation domain into the amino region, the RING
ﬁnger domain into the Core, and the Late Domains into
the Carboxyl region. Furthermore, other conserved islands
both between groups and within each group were described.
Although the role of these last domains is today unknown,
they could be a likely target for studies associated with the
arenavirus host range.
Simple methodologies that allowed Z protein expression
and facilitated its subsequent puriﬁcation were employed.
During the analysis of the Z protein expression in bacteria
it was not possible to obtain the product without a fusion
protein or tags. Probably, the reason for low Z protein yield
during puriﬁcation is its hydrophobicity, causing it to form
relatively insoluble intracellular inclusion bodies that must
be denatured. The Borden laboratory [28] discovered that
including Zn+2 in the IPTG-induction media or in the lysis
buﬀers greatly improved yields of recombinant Z protein.
Although we included Zn+2 in the puriﬁcation process,
we have not yet tested a puriﬁcation protocol that uses
denaturing buﬀers.
Several expression strategies were tested, including cell
hostswithdiﬀerent biological properties; it wasonly possible
to achieve the goal when Z’s amino terminus was fused to
a bacterial protein. This fusion stabilized the recombinant
protein and improved the expression levels.
In this work the over-expression of three diﬀerent
recombinant variants of Z protein: (1) Tio-Z-V5-His, (2)
GST-Z, and (3) His-Z, was achieved. This last fusion protein
was obtained from a baculoviral system in an insect cell line,
while the other two were obtained from bacterial systems.
The three variants of Z protein obtained can be cleaved from
their N-fusion protein; Tio-Z-V5-His after proteolysis keeps
the V5 epitope and the His tag.
Any of the expressed recombinant Z proteins could
be used to obtain polyclonal or monoclonal antibodies
that would allow immunological experiments to answer
questions about the molecular biology of Jun´ ın virus. For
example, studies of biological activity in diﬀerent cell lines,
cellular localization and protein interactions. Moreover, this
serum could be useful for aﬃnity chromatography designed
to allow simple puriﬁcation of Z protein without tags, or Z
protein obtained after proteolysis of its fusion partner.
Tio-Z-V5-His recombinant protein was selected for
antibody production, mainly because it showed the best
expression level and solubility. This fusion protein was used
for the generation of rabbit hyperimmune serum. Puriﬁed
IgG fraction for subsequent Western blotting and EIA, was10 Journal of Biomedicine and Biotechnology
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Figure 3: Expression, Puriﬁcation, and Cleavage of GST-Z. (a) Diagram of the recombinant GST-Z protein expressed in E. coli.T h e
dark gray region represents the glutathione-S-Transferase (GST) fusion protein; the striped block indicates the speciﬁc protease Factor
Xa. (IleGluGlyArg↓) target sequence; and the light gray arrow shows the Z protein. The molecular weight of the complete recombinant
protein is approx. 37 kDa, the cleavage products being ca. 25 kDa (GST) and ca. 11 kDa (Z). (b) 12% SDS-PAGE of a sample of the whole
cell culture at initial time (T0) and after 20h at 20
◦C( TF). (c) 15% SDS-PAGE of the puriﬁcation of GST-Z with glutathione Sepharose 4B
(Amersham). S: Supernatant from the whole cell lysate expressing GST-Z; V0: Lysate that ran through the column upon loading; W:W a s h
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PAGE, while the second peak corresponds to fractions 11 to 16. (e) 16% SDS-PAGE GST-Z cleavaged with the protease Factor Xa. The arrow
indicates the cleavage product corresponding to Z
  (11.56 kDa). T1:1h ;T2:2h ;T3:4h ;T4: 6h; and T5:1 6h ,a t3 7
◦C. (f) Western-blot of
the cleavage products of GST-Z with Factor Xa. The arrow indicates the Z
  protein. (g) 15% SDS-PAGE of the limited proteolysis of GST-Z
with Chymotrypsin (Roche). The protein products indicated with the symbols I, II, and III were sequenced at the N-terminus. The obtained
sequence is indicated adjacent to the diagram of GST-Z.
Table 2: Quantiﬁcation data for expression and puriﬁcation of GST-Z and Tio-Z-V5-His recombinants proteins.
GST-Z Tio-Z-V5-His
Step Relative Z-GST(%)1 Puriﬁcation factor Step Relative Tio-Z (%)1 Puriﬁcation factor
Total lysate 21 0.0 Total lysate 19 0.0
GST-aﬃnity2 88 4.1 Tio- aﬃnity 63 3.3
Gel ﬁltration2 91 4.2 Gel ﬁltration 94 4.9
1Soluble protein ratio (Z fussion protein/total protein). 2 Include degradation products of Z.Journal of Biomedicine and Biotechnology 11
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Figure 4: Z Protein Expression in Sf9 Insect Cell Line. (a) Diagram of the recombinant His-Z protein expressed on Sf9 Insect cell line.
The white region represents the His-tag; the squared block indicates the speciﬁc protease TEV (GluAsnLeuTyrPheGln↓Gly) target sequence;
and the gray arrow shows the Z protein. The molecular weight of the complete recombinant protein is 14 kDa, the cleavage products being
11kDa (Z) and 3kDa (His-TEV). (b) 16% SDS-PAGE of Sf9 cells infected with v Ac-Z. Lane 1 shows the Sf9 cells without infection. Lanes 2
and 3 correspond to the Sf9 cells infected with v Ac-Z at diﬀerent moi’s (1 and 5 resp.) after an incubation of 36h. The arrows have shown
the possible Z protein expression. (c) Western blotting with α-Tio-Z-V5-His. Total protein extracts from Sf9 cells infected with v Ac-Z
(recombinant AcMNPV expressing Jun´ ın Z protein; lanes 1 and 2) and AcMNPV (wild type baculovirus; lane 4) were loaded in the indicated
lanes. Lane 3 corresponds to the control of uninfected cells (ui). Tio-Z-V5-His puriﬁed sample was used as a positive control (indicated with
a red arrow). (d) Western blotting with α-His Tag polyclonal serum (Santa Cruz Biotechnology). Ultracentrifugated supernatant and cellular
extract of Sf9 cells infected with recombinant v Ac-Z was loaded in the indicated lanes. At the bottom of each lane the origin of the sample
is shown; Cell: Sf9 protein extract, UC pellet: ultracentrifugation pellet. Tio-Z-V5-His positive control is indicated with a red arrow.
also obtained. On the other side, the puriﬁed Tio-Z-V5-His
wasusedassubstratefortheENKreaction,inordertoobtain
Z-V5-His, employed as positive control in diﬀerent assays.
Tio-Z-V5-His and His-Z fusion proteins can be puriﬁed
by IMAC, since both peptides have His-Tags. However, this
puriﬁcation method could be counterproductive for the
puriﬁcation of native Z, since it is not known how Co+2 or
Ni+2 ions could modify Z structure by binding and aﬀecting
its RING ﬁnger domain. It was observed that the native
structure of Z protein contains two Zn+2 atoms, and other
transition metals could interfere with these sites [44].
On the other hand, the GST-Z fusion protein can
be puriﬁed by aﬃnity chromatography with glutathione
resins, without using immobilized metals. Its expression and
puriﬁcation was optimized with the aim to obtain the viral
protein without tags on its native conformation, ready for
crystallographic studies. The proteolysis of GST-Z protein
with Factor Xa, produced only two peptides: GST and Z.
The proteolysis reaction was successful because: (1) in SDS-
PAGE analysis, at diﬀerent times of the proteolysis reaction
with Factor Xa, decreasing of GST-Z and increasing of
individual GST and Z was observed; and (2) by Western blot12 Journal of Biomedicine and Biotechnology
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Figure 5: Western Blotting with α-Tio-Z-V5-His. (a) The ultracentrifugated supernatant (UC pellet) and cellular extract (Cell) of Sf9 cell
fractions infected with recombinant v Ac-Z were loaded in lanes 1 and 2. The same fractions were loaded for uninfected cells (ui, lanes 3 and
4) and control v dsRed (recombinant baculovirus expressing dsRed protein, lanes 5 and 6). (b) Proteinase K protection assay. The treatment
of the UC pellet samples (Triton X-100 1% and Proteinase K 0,1mg/ml) is indicated on the top of the ﬁgure.
analysis, the Z protein identity after the proteolysis reaction
was asserted (Figures 3(e) and 3(f)). Consequently, high
concentrations of Z protein (necessary for crystallographic
studies) could be obtained.
Inaddition, afterGST-Zpuriﬁcation,thepresenceoftwo
proteins that copuriﬁed with GST-Z was observed (indicated
with I in the Figure 3(g)). A similar phenomenon has been
previouslyreported[45].TheW esternblot,withIgGpuriﬁed
from polyclonal anti-Z serum recognized the GST-Z protein
andothercopuriﬁedpeptide(ca.29kDa),whilesthecontrol,
GST alone, did not generate signal. Nevertheless, apparently
this peptide is not a substrate of Factor Xa. In summary, the
copuriﬁed peptides had high aﬃnity for glutathione resin,
so they probably contained GST derived amino acids, and
one of them was recognized by the anti-Z serum, so it had Z
derived amino acids. To conﬁrm these facts the N-terminus
of the copuriﬁed peptides, and some peptides obtained
by limited proteolysis with chymotrypsin were sequenced
(Figure 3(g)). This assay allowed the identiﬁcation of
structured domains, which were less sensitive to proteolysis,
and could be better candidates for crystallographic studies.
We found that one of the copuriﬁed peptides, the one of
approximately 25 kDa, was stable even at high chymotrypsin
concentrations. The N-terminus of this peptide shared the
sequence with the ﬁrst six amino acids of GST, indicating
that degradation occurred by the carboxyl terminus of
the recombinant protein. The same results were obtained
after analyzing the N-terminus of the approximately 29
kDa copuriﬁed protein, which was also stable after the
chymotrypsin treatment. Thus, it was possible that these
low molecular weight peptides contained fragments of Z
protein at its C-terminus. Two of them were sequenced at
the N-terminus because, according to the molecular weight
estimated by the electrophoretical migration, the Z protein
sequence would be included (indicated with II and III in the
Figure 3(g)). We could not establish the C-terminal sequence
of the two copuriﬁed peptides, so we still do not know the
speciﬁc site of cleavage of GST-Z in order to determine a
stable domain. However, the approximate stable polypeptide
corresponds to most of GST, which is not of our interest for
crystallographic studies.
A subsequent approach to obtain Z protein in a native
conformation could take advantage of its interactions with
host proteins, such as the promyelocytic leukemia protein
(PML) and others; it might be possible to overexpress Z
and its interaction partner fused to a suitable tag for aﬃnity
puriﬁcation. This would allow the copuriﬁcation of the
complex by aﬃnity chromatography to later obtain native Z.
For Lassa arenavirus it was demonstrated that expression
of Z in mammalian cell lines was suﬃcient for budding
of “pseudo-virions” or Z-containing membranous particles
[46]. Apparently, glycine myristoylation at position 2 of
Zs e q u e n c ei sc r i t i c a lf o rt h i sp h e n o m e n o n[ 47–49]. This
glycine residue is completely conserved in Z protein from all
members of Arenaviridae (Figure 1). This suggests that all Z
homologueswithintheArenaviridaefamilyaremyristoylated
at this position. Currently, all reports of pseudo-virion bud-
ding employed mammalian cell lines. At the present it is not
known whether insect cell lines are capable of recognizing
this post-translational modiﬁcation signal present in Z, so
during this work we started testing this possibility.
When insect cell lines were used for Z expression, high
levels of expression were not achieved (Figure 4(b)). For this
system, Z was His-Tagged so it could be puriﬁed by IMAC
and then untagged by TEV protease cleavage. Interestingly,
Z was detected in the cellular fraction by means of Western
blottingwithα-Tio-Z-V5-HisIgGs,butitwasnotpossibleto
detect it using an anti α-His Tag antibody (Figures 4(c) and
4(d), resp.). The absence of His-Tag signal could indicate the
removaloftheHis-Tagfromtheprotein,byayetunidentiﬁed
cellular process, or possible protein degradation at this
particular site. Besides protein Western blot, a puriﬁcation
of the protein by IMAC was attempted, but no retention of
protein from a cellular protein extract was observed (data
not shown). Interestingly, when the cell culture supernatant
fraction was analyzed using a Proteinase K protection assay,
the results indicated that Z was included within small
lipid vesicles, although other conﬁrmatory assays such as
immuno electron microscopy will be required in order to
unambiguously conﬁrm this.
The next step will be to further investigate the Z-
membrane vesicles obtained from these cell lines. If N-
myristoylation of Z in insect cells is proven to be eﬀective, it
willbenecessarytomodifytheconstructionsforpuriﬁcation
purposes. The employment of insect cell lines would repre-
sent a much safer methodology to obtain virus like particlesJournal of Biomedicine and Biotechnology 13
[50],whichhavepotentialuseasvaccineagainstarenaviruses
for which successful treatment has not yet been established.
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